BACKGROUND: In 2001, the Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical guidelines for the treatment of depressive disorders. A revision of these guidelines was undertaken by CANMAT in 2008-2009 to reflect advances in the field. There is renewed interest in refined approaches to brain stimulation, particularly for treatment resistant major depressive disorder (MDD). METHODS: The CANMAT guidelines are based on a question-answer format to enhance accessibility to clinicians. An evidence-based format was used with updated systematic reviews of the literature and recommendations were graded according to Level of Evidence using pre-defined criteria. Lines of Treatment were identified based on criteria that included evidence and expert clinical support. This section on "Neurostimulation Therapies" is one of 5 guidelines articles. RESULTS: Among the four forms of neurostimulation reviewed in this section, electroconvulsive therapy (ECT) has the most extensive evidence, spanning seven decades. Repetitive transcranial magnetic (rTMS) and vagus nerve stimulation (VNS) have been approved to treat depressed adults in both Canada and the United States with a much smaller evidence base. There is also emerging evidence that deep brain stimulation (DBS) is effective for otherwise treatment resistant depression, but this is an investigational approach in 2009. LIMITATIONS: Compared to other modalities for the treatment of MDD, the data based is limited by the relatively small numbers of randomized controlled trials (RCTs) and small sample sizes. CONCLUSIONS: There is most evidence to support ECT as a first-line treatment under specific circumstances and rTMS as a second-line treatment. Evidence to support VNS is less robust and DBS remains an investigational treatment.
声明:此回答是一名长期抑郁症患者的经验总结,原文适用于中度抑郁症及以下自救,更新适用于想要关爱身边抑郁症患者的朋友。虽然本人读过不少关于抑郁症的书(此文设计基本概念都有权威出处),参加过一些关于抑郁,焦虑,自信心的正规医疗自救培训,但目前本人没有经过任何正规系统的专业学习,答案中的任何观点都属于完全业余,严肃问题请一定寻医问诊,欢迎指正。话题经验相关:我本人因为博士转专业和实验不顺长期抑郁。我有一个非常善良温柔三观正,并陪伴我多年的男朋友(非抑郁症),感谢他的存在。鉴于有太多很爱护自己另一半的朋友问我这个问题,想要为身边患有抑郁症的朋友做些什么却又不知道该怎么做;我觉得有必要在这里简明扼要地地说明几个问题及注意事项。又以及,鄙原文上传后的这些年获得了一些新的知识和感受,我在这里做一次更新。-20160527
青少年抑郁症的原因主要见于遗传因素,性格因素及患病前是否受过精神刺激。在这几种因素当中,家族遗传性因素对儿童抑郁症影响很大。经调查显示:大约有50%的抑郁症儿童父母中,至少有一人曾患过抑郁症,可见这个发病几率还是非常高的。   其次,性格特点是不容忽视的因素。很多孩子患病前具有以下这些性格缺陷:性格内向、文静,不爱交际,不喜欢出头露面,孤僻、多疑,经常注意到事物消极一面;还有些儿童病前多表现无能,被动,好纠缠,依赖和孤独的特点或是病前个性倔强,好攻击别人,这样的性格一旦受到意外打击后易患抑郁症。   最后,致病因素还与病前受过精神刺激有关。一般的患者在发病前都受过精神方面的刺激,如父母死亡或离异,父母对子女采取排斥或漠不关心的态度,早年曾患有严重的不幸经历,青春期遭遇精神创伤,或者身患疾病,人际关系的不协调,学习成绩不良等均可诱发抑郁症。
有一个特别特别关键的问题每个抑郁症患者都得遇到的,那就是抑郁症是不是自己的问题,是不是自己思想心态的问题。这个问题,也许医生和旁人可以很明确的回答说不是,这是抑郁症。每个深陷抑郁症的人都会很在意这个问题,包括我,我们都希望不是自己的问题(虽然又如上段所说的觉得是自己的问题才抑郁)。抑郁症,他当然是一个病,一般是抑郁久了身体里面缺乏让人有精力的化学因素(不懂不过类似)所以做什么都有气无力,表现得懒惰,厌世,什么也不做。这是有科学根据的病,病人不容易控制自己,严重了更有自杀或者幻觉等各种更加显而易见的症状。然而归根结底,抑郁这个状态,他是自我的因素,用俗话不负责任的话来说就是自我主观想不开导致的,所以是可以调节的,也就是为什么抑郁症是可以恢复的原因。然而,你千万不能给一个抑郁症的患者说你抑郁是你自己想不开,是懒惰,因为这不是事实。事实是想不开也分主观想不开和客观想不开,懒惰也分主动懒惰但是很爽每天开心得要死,和不愿意懒惰在抑郁期间每天无法集中精神,从而认为自己懒惰从而而更加憎恨自己。这会把他们推向万丈深渊,而且这也不是真的。抑郁症患者的他们的主观想不开,是由于各种客观原因导致的,这些因素可能包括遗传,生性敏感,人生变故,失恋,父母离婚,小的时候亲情缺失成长有隐患,遇人不淑工作出现重大阻碍,人生观崩塌等等等等。易宇恒的“无所事事,卧床不起,活着失眠不睡无法集中注意力等等”懒惰“的症状,是因为病情想不开,加上身体确实化学物质所造成的。
微课堂053(上)|刘文娟:精神科视角下的强迫症微课堂053 (下)|方萌: 心理咨询视角下的强迫症微课堂049|溪子:女性成长与身体焦虑微课堂048|马燕桃:双相情感障碍 “躁狂时让生命崩裂,低沉时让抑郁成诗”微课堂034 | 徐丽丽:独抚妈妈如何做好自己的情绪管理?|简 · 公益微课堂为了克服社交焦虑,这个女孩做了一场7天的社交实验微课堂018 | 孙平:愤怒的意义 抑郁症患者最需要的并不是解决问题的办法 如何陪伴“抑郁症”的家人或朋友抑郁症的影响“抑郁症”是什么(科普) 基因不决定你的命运(抑郁遗传吗?)【译】陆建华:女汉子的内心是孤独的定时喂猫器+征集问题抑郁怎么办爱是唯一道路(科学版)忧郁,周星驰 (电影背后的情绪表达)by李孟潮不必做孔融积极或不积极,这是一个问题《小王子》和永恒青少年情结如何陪伴“抑郁症”的家人或朋友抑郁症的治疗抑郁症的影响什么是抑郁症人际关系中的隐形攻击(被动攻击)治疗师之爱人人皆有分裂时抑郁怎么办值得欢庆你既行为 必有其因“朝圣”路上的“医治者”你问我答(1)Bye Bye Perfect动画 | 你容易迁怒于别人吗?动画 | 这孤独的云生啊 ~ 还好有你陪我谢谢你,听我说话【简 · 答题】没有办法向别人表述自己的真实想法【简 · 答题】太在意别人的一言一行【简 · 答题】抑郁症真的有出路吗?【简 · 答题】不合群怎么办?【简 · 答题】女生应该主动联系男生吗?【简 · 答题】不想受到妈妈的消极影响【简 · 答题】想理解「孤独」这份感受让自己被看见,是奇迹般的自然过程强遮双目也有其深刻意义一个“拖延症患者”的自白不要把所有事儿都归到抑郁症你能看到我的「 91厘米 」吗?脆弱时,你需要一只软萌的海豹~TED演讲:为什么情绪急救势在必行?未婚者的痛动画 | 你容易迁怒于别人吗?我没安全感,你能给我吗?咨询小悟关于自杀 | 看见并承认TA的痛苦把你的想法植入别人的脑袋里!!抑郁十二年6件你以为会让自己开心的事儿6件你以为会让自己开心的事儿我们一起去吃冰淇淋!我们一起去吃冰淇淋!漫画 | 罗夏医生的咨询室这8个问题,帮你和脑海中的消极声音抗争到底我没安全感,你能给我吗?动画 | 网购有风险,剁手需及时
As clinicians, we routinely make critical decisions for our patients with depression. Because of the uncertainty of factors that affect diagnosis and treatment, clinicians may find an objective, quick measurement tool helpful. Measurementbased care (MBC) provides specific and objective information on which to base clinical decisions and should therefore enhance quality of care and treatment outcomes. (1-3) MBC rests on these assumptions. * Compared with general questions that are typically asked during a patient evaluation, specific measurements (administered by clinicians or self-reported by patients) provide more accurate information on which to establish a diagnosis, assess treatment outcomes, and modify treatments. * Patients who complete these measurement tests will better understand their disorder and treatment effects, which will enable them to better manage their depression. * Medical records that include the results of specific measurements will assist subsequent clinicians in understanding the results of prior treatments. * The routine use of the same measurements in practice and clinical research studies will help clinicians translate research findings into their own practices. * For most outpatients with depression, self-report methods are available that are free and that take little time and effort. Diagnostic measurements Researchers have used criterion-based diagnostic methods for years. After DSM-III was introduced in 1980, the Structured Clinical Interviews for DSM-III (SCID) (and later for DSMIV) were developed to obtain lifetime diagnoses. (4,5) Briefer structured interviews were then developed, including the Mini-International Neuropsychiatric Interview (MINI), which assesses only current diagnoses, and the MINI-Plus, which elicits information about current and past diagnoses. (6-8) The MINI takes 30 to 40 minutes to administer, while the MINI-Plus may take up to 60 minutes. Studies have shown that structured or semistructured interviews provide more accurate diagnoses than typical practice. For example, clinically rendered diagnoses were compared with those made based on SCID results. (9) Major diagnostic differences were found in 40% of outpatients with clinical diagnoses of schizophrenia or bipolar or major depressive disorders. In addition, when clinicians were provided with a diagnosis that was determined using SCID, they changed the chart diagnosis in a substantial proportion of cases and prescribed fewer medications. (10) Symptom measurements Once a diagnosis has been made and therapy has been initiated, the regimen must often be modified because of intolerance, adverse effects, or other less-than-desirable symptomatic outcomes. Medication and somatic therapies are typically aimed at treating symptoms, but psychotherapy and disease self-management may also address other aspects of treatment (eg, medication adherence, social/occupational function, self-esteem). The Texas Medication Algorithm Project (TMAP) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) studies showed that diligent assessment of symptoms and adverse effects enhances outcomes. (11-14) The goal of therapy for depression is symptom remission and, ultimately, sustained remission and functional recovery. (15) Most patients require more than 1 treatment revision (eg, altered dosage, treatment, or delivery). When implementing guideline-driven or evidencebased care, initial treatment is continued until remission or maximal symptom improvement is obtained or until the patient cannot tolerate the regimen. Thereafter, the dosage or type of treatment may...

抗抑郁药物在治疗患有重度抑郁症或者更严重的成人中有很明显的效果(药物反应率为48%-50%,比安慰剂30-32%高出接近20个百分点)。另外也有部分研究发现结合多种抗抑郁药物,或者在早期增大SSRIs用量的话,疗效可能更好。而对于年龄65岁或者更老的患者,药物疗效的反应率与安慰剂的对比差异就没有那么大了。对于年龄小于13岁的小孩,药物和安慰剂的差异很小,并不显著。抑郁症同样对那些患有生理疾病的抑郁患者有效,但是在患有内科疾病(比如高血压,关节炎,肝炎)的患者中疗效较差。对于安慰剂效应,病情越重的抑郁症和忧郁症中安慰剂效应较小,反之,程度较轻,时间较短并且由之前的生活事件所引发的话抑郁症则安慰剂效应较大。当然,有很多研究争论说药物只在病症严重的患者中才有效果,其实并不是这样,虽然药物在程度严重的患者中效果更好,但是在程度较轻的患者中仍然有明显的医疗效果,而且值得注意的是即使不是精神类药物而是我们日常用的药物,它们的安慰剂与药效的对比其实也是相似的数据,只是我们大众和媒体平时过于关注精神类药物才导致我们觉得精神类药物效果差副作用大(这方面我之前的回答链接里有提到)。

×